Cerus

About:

Cerus is a biomedical products company focused in the field of blood safety.

Website: http://www.cerus.com/

Top Investors: Oxford Finance LLC

Description:

Cerus Corporation is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development.

Total Funding Amount:

$236M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Concord, California, United States

Founded Date:

1991-09-01

Founders:

B.J. Cassin, Laurence M. Corash, Stephen T. Isaacs

Number of Employees:

251-500

Last Funding Date:

2020-01-28

IPO Status:

Public

Industries:

© 2025 bioDAO.ai